Zinzino Reports 18% Revenue Growth in Preliminary Q3 2026 Sales Figures

Quarterly numbers

Zinzino has released its preliminary sales results for the third quarter of 2026. Group revenue for the quarter rose 18% year over year to $31 million.

Within that total, the company's sales markets grew 15% year over year to approximately $30 million. External sales at Faun Pharma came to $64,000 for the period.

Nine-month performance

On a cumulative basis, revenue for the first nine months of 2026 increased 21% year over year, reaching $277 million.

The figures are preliminary and relate to sales only, with Zinzino reporting them ahead of its fuller quarterly disclosure.

Regional breakdown

South America delivered the strongest third-quarter growth of any region, expanding 189% compared with the same quarter a year earlier. The company identifies Peru and Colombia as the markets in that grouping.

North America — comprising Canada, the United States and Mexico — recorded 55% growth for the quarter.

The Asia-Pacific region posted 48% year-over-year growth. Zinzino counts Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, the Philippines and South Korea within that territory.